Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA

American Journal of Pathology

Volumn 162, Issue 6, 2003, Pages 1781-1787

  Chun Ling Lin, Valerie ^a   Jin, Rongxian ^b   Tan, Puay Hoon ^a   Aw, Swee Eng ^a   Woon, Chow Thai ^a   Bay, Boon Huat ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; KERATIN; PROGESTERONE; PROGESTERONE RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0037568442     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9440(10)64313-1     Document Type: Article

References (40)

1. Russo J, Yu YF, Silva IDCG, Russo IH: Cancer risk related to mammary gland structure. Microsc Res Tech 2001, 52:204-223
2. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278
3. Beato M, Herrilch P, Schutz G: Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857
4. Key TJ: Hormones and cancer in humans. Mutat Res 1995, 333:59-67
5. Moore MR, Hathaway LD, Bircher JA: Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D. Biochim Biophys Acta 1991; 1096:170-174
6. Kallkhoven E, Kwakkenbos-Isobruicker L, de Laat SW, Van der Saag PT, Van der Burg B: Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol 1994, 102:45-52
7. Kester HA, Van der Leede BM, Van der Saag PT, Van der Burg B: Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem 1997, 272:16637-16643
8. Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Chan VSW, Ho GH: Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. Clin Cancer Res 1999, 5:395-403
9. Lin VCL, Aw SE, Ng EH, Ng EHL, Chowdhury SH: Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231. Clin Cancer Res 2001, 7:2880-2886
10. Ackland ML, Michalczyk A, Whitehead RH: PMC42, a novel model for the differentiated breast. Exp Cell Res 2001, 263:14-22
11. Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Bay BH: Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor cDNA. Mol Endocrinol 2000, 14:348-358
12. rd edn. Baltimore, Williams & Wilkins, 1995, pp 373-374
13. Sacchi TB, Bani D, Brandi ML, Falchetti A, Bigazzi M: Relaxin influences growth, differentiation and cell-cell adhesion of human breast cancer cells in culture. Int J Cancer 1994, 57:129-134
14. Shirayoshi Y, Okada TS, Takeichi M: The calcium-dependent cell-cell adhesion system regulates inner cell mass formation and cell surface polarization in early mouse development. Cell 1983, 35:631-638
15. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994, 31:325-335
16. Grunberg E, Eckert K, Karsten U, Maurer HR: Effects of differentiation inducers on cell phenotypes of cultured nontransformed and immortalized mammary epithelial cells: a comparative immunocytochemical analysis. Tumor Biol 2000, 21:211-223
17. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991, 51:6328-6337
18. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993, 53:1696-1701
19. Guriec N, Marcellin L, Gairard B, Calderoli H, Wilk A, Renaud R, Bergerat JP, Oberling F: E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis 1996, 16:19-26
20. Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP: Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120cas) in bladder tumors. Cancer Res 1996, 56:4154-4158
21. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997, 112:46-54
22. Asgeirsson KS, Olafsdottir K, Jonasson JG, Ogmundsdottir HM: The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine 1998, 10:720-728
23. Vessey CJ, Wilding P, Folarin N, Hirano S, Takeichi M, Soutter P, Stamp GW, Pignatelli M: Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995, 176:151-159
24. Khare L, Sabourin CL, De Young BR, Jamasbi RJ, Stoner GD: Altered localization of E-cadherin and α-catenin in rat esophageal tumors. Int J Oncol 1999, 14:33-40
25. Sadot E, Geiger B, Oren M, Ben-Ze'ev A: Down-regulation of β-catenin by activated p53. Mol Cell Biol 2001, 20:6768-6781
26. Charpin C, Bonnier P, Garcia S, Andrac L, Crebassa B, Dorel M, Lavaut MN, Allasia C: E-cadherin and β-catenin expression in breast medullary carcinomas. Int J Oncol 1999, 15:285-292
27. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC: β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000, 97:4262-4266
28. Fawcett DW, Jensh RP: Bloom & Fawcett's concise histology, ed 2. London, Arnold, 2002, pp 15-18
29. Seshadri R, Raymond WA, Leong AS, Horsfall DJ, McCaul K: Vimentin expression is not associated with poor prognosis in breast. Int J Cancer 1996, 67:353-356
30. Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P: p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J Clin Pathol 2002, 55:461-466
31. Jones CB, Clements MK, Redkar A, Daoud SS: UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells. Int J Oncol 2000, 17:1043-1051
32. Gilbert SF: Dev Biol, ed 5. Massachusetts, Sinauer Associates, Inc., 1997, pp 391-504
33. Lange C, Richer JK, Horwitz KB: Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 1999, 13:829-836
34. Darnell JE Jr: STATS and gene regulation. Science 1997, 277:1630-1635
35. Richer JK, Lange C, Manning G, Owen G, Powell R, Horwitz KB: Convergence of progesterone with growth factor and cytokine signaling in breast cancer. J Biol Chem 1998, 273:31317-31326
36. Bromberg JF: Activation of STAT proteins and growth control. Bioessays 2001, 23:161-169
37. Mui A L-F: The role of STATs in proliferation, differentiation, and apoptosis. Cell Mol Life Sci 1999, 55:1547-1558
38. Kaplan DH, Shanjaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD: Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998, 95:7556-7561
39. Al-Shami A, Mahanna W, Naccache PH: Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils: selective activation of Jak2, Stat3, and Stat 5b. J Biol Chem 1998, 273:1058-1063
40. Behrens J: Cell contacts, differentiation and invasiveness of epithelial cells. Invasion Metastasis 1994, 14:61-70